Navigation path

Themes
Agriculture & food
Energy
Environment
ERA-NET
Health & life sciences
  Allergy & asthma
  Biotechnology
  Communicable diseases
  Drugs & drug processes
  Genetic engineering
  Genomics
  Health & ageing
  Health & poverty
  Health & special needs
  Health systems & management
  Major diseases
  Medical research
  Molecular biology
  Neuroscience
  Public health
  Rare & orphan diseases
  Other
Human resources & mobility
Industrial research
Information society
Innovation
International cooperation
Nanotechnology
Pure sciences
Research infrastructures
Research policy
Science & business
Science in society
Security
SMEs
Social sciences and humanities
Space
Special Collections
Transport

Countries
Countries
  Argentina
  Australia
  Austria
  Belgium
  Benin
  Brazil
  Bulgaria
  Canada
  Chile
  China
  Croatia
  Cyprus
  Czech Republic
  Denmark
  Egypt
  Estonia
  Finland
  France
  Georgia
  Germany
  Ghana
  Greece
  Hungary
  Iceland
  India
  Ireland
  Israel
  Italy
  Japan
  Kazakhstan
  Kenya
  Korea
  Latvia
  Lithuania
  Luxembourg
  Malta
  Montenegro
  Morocco
  Namibia
  Netherlands
  Nigeria
  Norway
  Peru
  Poland
  Portugal
  Romania
  Russia
  Serbia
  Slovakia
  Slovenia
  South Africa
  Spain
  Swaziland
  Sweden
  Switzerland
  Taiwan
  Tunisia
  Turkey
  Ukraine
  United Kingdom
  United States


This page was published on 12/11/2007
Published: 12/11/2007

   Success Stories

Last Update: 12-11-2007  
Related category(ies):
Information society  |  Health & life sciences

 

Add to PDF "basket"

RFID and healthcare: a revolutionary friendship

Today, smart radio tags, known technically as Radio Frequency Identification (RFID), can be used for the storing and remote retrieval of data from, for example, patients, drugs or tissue samples. The integrated electronic circuit in the tag stores information which can be updated whenever necessary – a crucial feature that could revolutionise the information process in hospitals and improve healthcare throughout Europe.

Video in QuickTime format:  de  en  es  fr  it  pt  ru  (33 MB)

Back in 2003, Dr Daniel Grandt, head of the Internal Medicine Department at the Saarbruecken Clinic in Germany, discovered the potential of RFID to improve the quality of treatments. A prototype was developed, shaped like a watch; using a "reader", a doctor could access patients’ information, e.g., their illness, medical records and current drug treatments. The result: faster treatments and better traceability of prescribed drugs.

However, it soon became clear that there was a risk of information contamination from one patient to the next as doctors visited successive patients. To solve this problem, Simone Grandt launched a new RFID project: the new approach replaces the "readers" with mobile telephones. The RFID tag sends the patient's data to the doctor's mobile phone, which in turn sends the data to the doctor's computer via a Wi-Fi link.

This process is particularly helpful for doctors who have a large case load of patients. Moreover, dedicated software helps doctors to prescribe drugs. Indeed, according to Dr Grandt, studies show that "around 5 percent of patients need hospital treatment for the side effects of drugs". With about 50 000 approved drugs in Europe and more than 8 000 known side effects, it is difficult for doctors to remember all the information about each drug. The software alerts the doctor to possible side effects given the patient’s medical status and history.

RFID is also being tested at the Institute Paoli Calmettes (IPC), in Marseille, France. Its Centre de Thérapie Cellulaire et Génique hosts one of Europe's largest tumour banks, with around 120 000 specimens for studying cancer development. Since 2000, RFID tags have been undergoing tests for labelling and identifying specimens. For RFID labelling, with there is one major problem: tumour samples are stored in fridges at -80°C or in liquid nitrogen tanks at -180°C. RFID tags do not work below -80°C. This means the chips become inactive and cannot be read or rewritten. Only once the temperature climbs can the tag again be of any use.

Working with RFID developers, Paoli-Calmettes' researchers are attempting to overcome such hurdles. They are convinced RFID labelling can be a real advantage for managing the Tumour Bank as the current labelling method uses barcodes which cannot hold as much information. In addition, the information cannot be rewritten and is not as simple to read as the signal sent from the RFID tags.

In response to some critics who argue that the technology is an intrusion into people's lives, the researchers involved believe that, as long as the method is well managed, sensitive information can be protected while giving the opportunity for better treatment. However, as healthcare staff underline, more investment is required before ethical and technical issues can be resolved. Only then can Europeans receive the RFID benefits of more efficient healthcare.

Convert article(s) to PDF

No article selected


loading


Search articles

Notes:
To restrict search results to articles in the Information Centre, i.e. this site, use this search box rather than the one at the top of the page.

After searching, you can expand the results to include the whole Research and Innovation web site, or another section of it, or all Europa, afterwards without searching again.

Please note that new content may take a few days to be indexed by the search engine and therefore to appear in the results.

Print Version
Share this article
See also

Futuris, the European research programme - on Euronews. The video on this page was prepared in collaboration with Euronews for the Futuris programme.

Contacts
Jan Hens
European Commission,
Information Society and Media DG,
Information and Communication Assistant,
Information and Communication Unit (S3),
Tel.: +32 2 29 68855
Email: jan.hens@ec.europa.eu

Unit A1 - External & internal communication,
Directorate-General for Research & Innovation,
European Commission
Tel : +32 2 298 45 40
  Top   Research Information Center